相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of Integrase inhibitors and tenofovir alafenamide on weight gain in people with HIV
Jordan E. Lake et al.
CURRENT OPINION IN HIV AND AIDS (2021)
Modelling the cost effectiveness of non-alcoholic fatty liver disease risk stratification strategies in the community setting
Stephen E. Congly et al.
PLOS ONE (2021)
Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)
Jenny Bischoff et al.
ECLINICALMEDICINE (2021)
Poor Concordance Between Liver Stiffness and Noninvasive Fibrosis Scores in HIV Infection Without Viral Hepatitis
Ditte Marie Kirkegaard-Klitbo et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV-monoinfected patients
G. Sebastiani et al.
HIV MEDICINE (2020)
Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
Rod S. Taylor et al.
GASTROENTEROLOGY (2020)
New Drugs for NASH and HIV Infection: Great Expectations for a Great Need
Giovanni Guaraldi et al.
HEPATOLOGY (2020)
Decompensated cirrhosis is the commonest presentation for NAFLD patients undergoing liver transplant assessment
Ahmed Hussain et al.
CLINICAL MEDICINE (2020)
2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0
L. Ryom et al.
HIV MEDICINE (2020)
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Peter J. Eddowes et al.
GASTROENTEROLOGY (2019)
Clinical significance of elevated liver transaminases in HIV-infected patients
Jia Cai et al.
AIDS (2019)
Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease
Ankur Srivastava et al.
JOURNAL OF HEPATOLOGY (2019)
Dietary Patterns and Components in Nonalcoholic Fatty Liver Disease (NAFLD): What Key Messages Can Health Care Providers Offer?
Kiarash Riazi et al.
NUTRIENTS (2019)
Estimated costs of 51 commonly ordered laboratory tests in Canada
Irene Ma et al.
CLINICAL BIOCHEMISTRY (2019)
Introduction: Standards of Medical Care in Diabetes-2019
[Anonymous]
DIABETES CARE (2019)
Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study
Maud Lemoine et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2019)
Impact of Implementing a FIB-4 First Strategy on a Pathway for Patients With NAFLD Referred From Primary Care
Tracy Davyduke et al.
HEPATOLOGY COMMUNICATIONS (2019)
Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection
Amine Benmassaoud et al.
PLOS ONE (2018)
Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono-infection under long-term combined antiretroviral therapy
Hugo Perazzo et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2018)
Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis
Thomas Pembroke et al.
JOURNAL OF HEPATOLOGY (2017)
Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis
Thomas Karlas et al.
JOURNAL OF HEPATOLOGY (2017)
Liver test abnormalities in patients with HIV mono-infection: assessment with simple noninvasive fibrosis markers
Rosa Lombardi et al.
ANNALS OF GASTROENTEROLOGY (2017)
Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patients
Maud Lemoine et al.
AIDS (2017)
Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfection
James B. Maurice et al.
AIDS (2017)
Metabolic concerns in aging HIV-infected persons: from serum lipid phenotype to fatty liver
Giovanni Guaraldi et al.
AIDS (2017)
Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients
Elise Vuille-Lessard et al.
AIDS (2016)
Liver fibrosis and fatty liver in Asian HIV-infected patients
G. Lui et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
The Globalization of Nonalcoholic Fatty Liver Disease: Prevalence and Impact on World Health
Mary Rinella et al.
HEPATOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Giulio Marchesini et al.
JOURNAL OF HEPATOLOGY (2016)
Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy
Caryn G. Morse et al.
CLINICAL INFECTIOUS DISEASES (2015)
Clinical, biochemical and histological differences between HIV-associated NAFLD and primary NAFLD: a case-control study
I. Vodkin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Liver fibrosis in HIV: which role does HIV itself, long-term drug toxicities and metabolic changes play?
Juergen K. Rockstroh et al.
CURRENT OPINION IN HIV AND AIDS (2014)
Non-alcoholic fatty liver disease
Naveed Sattar et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2013)
Hepatic Steatosis in Human Immunodeficiency Virus A Prospective Study in Patients Without Viral Hepatitis, Diabetes, or Alcohol Abuse
Richard K. Sterling et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management
Maud Lemoine et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2012)
Noninvasive Methods to Assess Liver Disease in Patients With Hepatitis B or C
Laurent Castera
GASTROENTEROLOGY (2012)
HIV Monoinfection Is Associated With Increased Aspartate Aminotransferase-to-Platelet Ratio Index, a Surrogate Marker for Hepatic Fibrosis
Jennifer C. Price et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population
Giovanni Guaraldi et al.
CLINICAL INFECTIOUS DISEASES (2011)
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease
Stuart McPherson et al.
GUT (2010)
Liver Damage Underlying Unexplained Transaminase Elevation in Human Immunodeficiency Virus-1 Mono-infected Patients on Antiretroviral Therapy
Patrick Ingiliz et al.
HEPATOLOGY (2009)
Nonalcoholic Fatty Liver Disease Among HIV-Infected Persons
Nancy Crum-Cianflone et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: Prevalence, characteristics, and predictors
Giovanni Guaraldi et al.
CLINICAL INFECTIOUS DISEASES (2008)
Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
S. A. Harrison et al.
GUT (2008)
FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and FibroTest
Adays Vallet-Pichard et al.
HEPATOLOGY (2007)
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Paul Angulo et al.
HEPATOLOGY (2007)
Altered hepatic expression of SREBP-1 and PPARγ is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients
M Lemoine et al.
AIDS (2006)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
CT Wai et al.
HEPATOLOGY (2003)
分享论文
